WallStreetZenWallStreetZen

NASDAQ: CALC
Calcimedica Inc Stock

$4.60-0.28 (-5.74%)
Updated Jul 17, 2024
CALC Price
$4.60
Fair Value Price
$1.23
Market Cap
$49.45M
52 Week Low
$1.75
52 Week High
$8.38
P/E
-2.14x
P/B
2.87x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$14.94M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.57
Operating Cash Flow
-$25M
Beta
0.59
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CALC Overview

Graybug Vision, Inc. is a clinical-stage biopharmaceutical company developing treatments of retina and optic nerve diseases. Known as Graybug LLC until 2016, Graybug Vision was incorporated in 2011 and is based in Redwood City, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CALC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CALC ($4.60) is overvalued by 273.49% relative to our estimate of its Fair Value price of $1.23 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CALC ($4.60) is not significantly undervalued (273.49%) relative to our estimate of its Fair Value price of $1.23 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CALC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CALC due diligence checks available for Premium users.

Be the first to know about important CALC news, forecast changes, insider trades & much more!

Valuation

CALC fair value

Fair Value of CALC stock based on Discounted Cash Flow (DCF)
Price
$4.60
Fair Value
$1.23
Overvalued by
273.49%
CALC ($4.60) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CALC ($4.60) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CALC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CALC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.14x
Industry
-21.17x
Market
30.24x

CALC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.87x
Industry
6.35x
CALC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CALC's financial health

Profit margin

Revenue
$0.0
Net Income
$130.0k
Profit Margin
0%
CALC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$27.1M
Liabilities
$9.9M
Debt to equity
0.57
CALC's short-term assets ($26.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CALC's short-term assets ($26.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CALC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.7M
Investing
-$13.1M
Financing
$19.0M
CALC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CALC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CALC$49.45M-5.74%-2.14x2.87x
KZR$49.43M+4.46%-0.49x0.29x
NXTC$49.23M-1.12%-0.77x0.50x
ELTX$49.19M+4.81%-0.56x10.10x
RPHM$49.80M-1.97%-0.68x0.61x

Calcimedica Stock FAQ

What is Calcimedica's quote symbol?

(NASDAQ: CALC) Calcimedica trades on the NASDAQ under the ticker symbol CALC. Calcimedica stock quotes can also be displayed as NASDAQ: CALC.

If you're new to stock investing, here's how to buy Calcimedica stock.

What is the 52 week high and low for Calcimedica (NASDAQ: CALC)?

(NASDAQ: CALC) Calcimedica's 52-week high was $8.38, and its 52-week low was $1.75. It is currently -45.11% from its 52-week high and 162.86% from its 52-week low.

How much is Calcimedica stock worth today?

(NASDAQ: CALC) Calcimedica currently has 10,749,065 outstanding shares. With Calcimedica stock trading at $4.60 per share, the total value of Calcimedica stock (market capitalization) is $49.45M.

Calcimedica stock was originally listed at a price of $231.00 in Sep 25, 2020. If you had invested in Calcimedica stock at $231.00, your return over the last 3 years would have been -98.01%, for an annualized return of -72.9% (not including any dividends or dividend reinvestments).

How much is Calcimedica's stock price per share?

(NASDAQ: CALC) Calcimedica stock price per share is $4.60 today (as of Jul 17, 2024).

What is Calcimedica's Market Cap?

(NASDAQ: CALC) Calcimedica's market cap is $49.45M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Calcimedica's market cap is calculated by multiplying CALC's current stock price of $4.60 by CALC's total outstanding shares of 10,749,065.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.